Who gains from saving nature
Ledger 1 : 33 — For each dollar financing nature-based solutions in 2023, about $33 financed activities harmful to nature. (UNEP)
Cases / Genetic resources and benefit-sharing · Brazil · date not stated

Brazilian court halts Bayer licence fees on Intacta soy after patent expiry

Short record: the main facts, with sources. A full case file has not been prepared.

Nature's voice · report
No measurement of the harm done to me here is on record.
Did nature suffer? Not measured.
Not on record
  • The record does not name which of my species, waters, soils or forests were harmed.
What the record lacks: 3 none on record · 1 not measured See the gaps

A Mato Grosso court halted Bayer's collection of licence fees on Intacta soy under expired patents, and an appeals court upheld the ruling. The case is pending before a higher court, with about 10 billion reais at stake.

What?
A Mato Grosso court halted Bayer's collection of Intacta soy licence fees under patents that had expired; the ruling was upheld on appeal. Revista Cultivar
Where?
Mato Grosso state, Brazil Revista Cultivar
When?
Reported in 2025; the start of the fee collection and the dates of the court rulings are not stated. Revista Cultivar
Who?
Gained
  • Bayer — Sought licence fees on Intacta soy after the underlying patents expired; collection was halted Revista Cultivar
Lost
None on record
Harmed
None on record
Why?
The fees were charged on patents that had expired; the courts' reasoning is not stated in the sources reviewed. Revista Cultivar
How?
Licence fees were charged on Intacta soy seed under patents that had expired, and the court halted their collection. Revista Cultivar
6 of 6 questions answered from the record

What happened

The record, in order.

Revista Cultivar reported in 2025 that a Mato Grosso court halted Bayer's collection of licence fees on Intacta soy under expired patents.

The state appeals court upheld the ruling, and the case is pending before a higher court.

The report puts the value of the case at about 10 billion reais.

    In court and with insurers

    Every proceeding and every insurer decision on record.

    Lawsuits and rulings

    1. Ongoing
      Mato Grosso Intacta royalty case
      Mato Grosso state courts (Brazil) · Civil · Not stated in the sources reviewed → Bayer

      A Mato Grosso court halted collection of licence fees on Intacta soy under expired patents; the state appeals court upheld the ruling, and the case is before a higher court. Revista Cultivar

    Insurers

    No insurer decision on record.

    What we don't know

    Undisclosed, unproven, untried: recorded as data.

    Nature

    • Not measured Harm to nature: The record holds no measurement of harm to nature.

    Record

    • None on record Who paid the fees, and how much was collected, is not stated in the sources reviewed.
    • None on record The dates of the first-instance and appeal rulings are not stated.
    • None on record The claimant in the Mato Grosso case is not named in the sources reviewed.

    Did the harm stop?

    Not stated in the sources reviewed.

    Who paid?

    Not stated in the sources reviewed.

    Sources

    Voices on record: — Company or project— Government and regulators— Courts✓ Press and investigations— Communities and civil society— Researchers

    Press and investigations

    Connected cases

    Related matters, and cases linked to this one through the same organisations, with the role each played in both.
    Similar cases
    Genetic resources and benefit-sharing · Brazil · 2014–2024
    Brazil: benefit-sharing fund (FNRB) and IBAMA biopiracy fines
    Same type: Genetic resources and benefit-sharingSame countryHarm to nature not measured
    Genetic resources and benefit-sharing · International · 2004–2025
    FAO Plant Treaty multilateral system and benefit-sharing fund
    Same type: Genetic resources and benefit-sharingSame regionHarm to nature not measured
    Genetic resources and benefit-sharing · Peru · 2020–2026
    Peru says it blocked 180 biopiracy cases, but records no benefit payments
    Same type: Genetic resources and benefit-sharingSame regionHarm to nature not measured
    Genetic resources and benefit-sharing · India · 2004–2022
    Turmeric, neem, basmati, Nap Hal patent revocations
    Same type: Genetic resources and benefit-sharingHarm to nature not measured
    Genetic resources and benefit-sharing · Global · 2025–2026
    WHO Pandemic Agreement and the PABS annex
    Same type: Genetic resources and benefit-sharingHarm to nature not measured
    Genetic resources and benefit-sharing · Indonesia · 2007–2026
    Indonesia's H5N1 sample withholding and the WHO PIP Framework
    Same type: Genetic resources and benefit-sharingHarm to nature not measured